In breast cancer and other tumor types, pRB is lost either by direct mutations/deletions/promoter methylation and silencing of the RB gene, or by hyper-phosphorylation of the pRB protein through loss of p16INK4A or amplification and activation of cyclin D1, cyclin E and CDK4 [59,106]. The gene discussed is RB1; the disease is breast cancer.